Moreover, SHP2 mediates immunoinhibitory receptor signaling, including PD-1 and cytotoxic T lymphocyte-associated protein 4 (CTLA-4)66; accordingly, it has been found that SHP2 deletion in T cells promotes tumor growth and metastasis67. This evidence concerns the gene CTLA4 and neoplasm.